Minneapolis Veterans Affairs Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Minneapolis Veterans Affairs Medical Center sits in the top decile of US sponsors by registered trial count (#568 of 15,742 sponsors by registered trial count).

28 total trials 2 currently recruiting 19 completed early-phase tilt top decile by trial count

Minneapolis Veterans Affairs Medical Center: 28 sponsored US clinical trials, 2 recruiting.

Minneapolis Veterans Affairs Medical Center sponsors 28 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 19 completed. 5 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Traumatic Brain Injury, with 3 trials.

Top-decile sponsor footprint

Minneapolis Veterans Affairs Medical Center ranks in the top decile of sponsors by registered trial count (#568 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 46/100

19 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

28 total, page 1 of 1

RECRUITING NA

Reaching Rural Veterans: Applying Mind-Body Skills for Pain Using a Whole Health Telehealth Intervention - UH3

NCT07541599

RECRUITING NA

Remote Stimulation and Training to Advance Recovery From TBI in Seniors

NCT07332299

ACTIVE NOT RECRUITING NA

Combined tDCS and Cognitive Training to Reduce Impulsivity in Patients With Traumatic Brain Injury

NCT03844607

ACTIVE NOT RECRUITING Phase 2

Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury

NCT02849223

COMPLETED NA

Reaching Rural Veterans: Applying Mind-Body Skills for Pain Using a Whole Health Telehealth Intervention - UG3 Pilot Study

NCT06568250

NOT YET RECRUITING Phase 2

Ketamine Treatment for PTSD and MDD in TBI

NCT06228391

COMPLETED Phase 1

Ketamine and Prolonged Exposure in PTSD

NCT03960658

COMPLETED

Women's-Specific Footwear With Prosthetic Feet

NCT03673371

COMPLETED NA

tDCS for Impulsivity and Compulsivity in Obesity

NCT04405089

COMPLETED NA

Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness

NCT02663349

COMPLETED Phase 2

Gulf War Illness Inflammation Reduction Trial

NCT02506192

COMPLETED Phase 1

Ketamine Infusions for PTSD and Treatment-Resistant Depression

NCT02577250

COMPLETED Phase 3

Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)

NCT01446029

COMPLETED Phase 2

Military to Civilian: Trial of an Intervention to Promote Postdeployment Reintegration

NCT00640445

COMPLETED NA

Effect of Pasta on Blood Glucose Response in Normal Subjects

NCT01469312

COMPLETED NA

Metabolic Response to 3-day Fast Versus Carbohydrate-free Diet in Type 2 Diabetes

NCT01469104

COMPLETED NA

Effect of Case-Management Using Home Monitoring on Diabetes and Blood Pressure Outcomes

NCT00935441

COMPLETED Phase 3

Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00914810

COMPLETED Phase 1

N-acetylcysteine in Alcohol Dependence

NCT00568087

TERMINATED NA

Comparison of a Metal Backed Fixed-Bearing Tibial Baseplate and an All-Polyethylene Tibia in Total Knee Arthroplasty

NCT00979147

COMPLETED NA

Effect of Care Management on Diabetes Outcomes

NCT00569556

COMPLETED Phase 2

Safety and Efficacy of Botulinum Toxin A Injection in Patients With Painful Artificial Knee Arthroplasty (TKA)

NCT00403273

TERMINATED Phase 2

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

NCT00557206

COMPLETED NA

Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts

NCT00328991

TERMINATED Phase 3

Gabapentin for the Treatment of Neuroleptic-Induced Tremor

NCT00533455

COMPLETED Phase 1

Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery

NCT00211653

TERMINATED Phase 4

Comparison of Mobile-Bearing and Fixed-Bearing All-Polyethylene Tibia Total Knee Designs

NCT00894361

COMPLETED Phase 4

Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)

NCT00000444

Phase Distribution

PhaseTrial count
Phase 1 4
Phase 2 6
Phase 3 3
Phase 4 2

What is open in the Minneapolis Veterans Affairs Medical Center pipeline

2 recruiting of 28 indexed (7% open); 19 completed (68%).

Phase mix: 5 late (III/IV) vs 10 early (I/II) (early-phase heavy).

Top condition: Traumatic Brain Injury (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Minneapolis Veterans Affairs Medical Center: open-pipeline peers nationwide

Peers matched on 28 registered trials and 7% open enrollment, not the therapeutic-area sidebar.

Minneapolis Veterans Affairs Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400 0%5%10%15%20%25% Total trials Recruiting share Minneapolis Veterans Affairs Medical CenterAxsome TherapeuticsBenaroya Research InstituteCAMC Health SystemCTI BioPharmaCarol Fabian, MDCelldex TherapeuticsKaiser PermanenteMannkind Corporation
Minneapolis Veterans Affairs Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Minneapolis Veterans Affairs Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 28 trials (± recruiting share)

Sponsors near 7% open enrollment (± trial volume)

What to do with this Minneapolis Veterans Affairs Medical Center page

28 registered trials is a research-attention snapshot, not an endorsement of Minneapolis Veterans Affairs Medical Center or any single study.

  • 2 of Minneapolis Veterans Affairs Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Traumatic Brain Injury is the condition Minneapolis Veterans Affairs Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Traumatic Brain Injury trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Minneapolis Veterans Affairs Medical Center pipeline card: 28 registered trials from official public datasets.Report a data error.